Such a privilege to be able to present the results from a truly collaborative project at #EANM ! Bio21 Institute Peter Mac Cancer Centre Telix Pharmaceuticals
The prosticpreceptorship2022.org would not be possible without our Gold Sponsors #PSMA Telix Pharmaceuticals Peter Mac Research Peter Mac Cancer Centre Michael Hofman Declan Murphy Arun Azad Renu Eapen
Explore the opportunities around Next Generation Nuclear Medicine at this #Tech23 Circle happening tomorrow!
You'll be joined by reps of Telix Pharmaceuticals ANSTO OncoSil Medical #Glytherix + more at this free, interactive event!
You can find out more and join at tech23.com.au/2020/circles/
ARTMS and Telix Pharmaceuticals announce successful production of #PSMA11 using multi-Curie quantities of #cyclotron -produced #Gallium68 via ARTMS’ proprietary QUANTM Irradiation System ( #QIS ) #solidtarget technology: bit.ly/3nE8X0C
#ProstateCancer #PET #MedicalIsotope
Neeraj Agarwal, MD, FASCO Telix Pharmaceuticals Brian Shuch, MD OncoAlert KidneyCAN @KidneyCancer Kidney Cancer Sumanta K. Pal, MD, FASCO Tian Zhang, MD, MHS Toni Choueiri, MD Pedro C Barata Umang Swami GU Cancer Research Program @HuntsmanCancer Simon C Nazli Dizman Nicolas Sayegh Brian- great work!
Listen as industry leaders explore how the Aust #research environment is presently working.What support is needed to ensure Aust provides a competitive market for conducting research & trials in the future?Register bit.ly/3n5pIDZ
Telix Pharmaceuticals CLARITY GenesisCare
Simon C Shankar Siva ASCO Michael Hofman Peter Mac GU Oncology Piet Ost Himanshu Nagar Chad Tang, MD Toni Choueiri, MD Sumanta K. Pal, MD, FASCO Craig Gedye DrAndrewWeickhardt Brian Shuch, MD Axel S. Merseburger Hans Hammers Ravi Barod Tom Powles Brian Rini, MD Reminds me also that I wrote an editorial about 10 yrs ago about CAIX and it’s possible role for diagnostics: bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj… Telix Pharmaceuticals BJU International
Construction at our European manufacturing site has commenced.
The state-of-the-art radiopharmaceutical production facility in Belgium will serve as our primary manufacturing site in Europe and a hub for R&D.
More on our website: bit.ly/3ttu4Ju
#TelixPharma #TelixEMEA
Jeremie Calais Michael Hofman ASCO Shankar Siva We are starting a new trial in HR PCa with PSMA at baseline and at PSA increase. Maybe I should try to get a grant to get a PET at 3 mo and 12 mo for the first 100 pts to learn more? Telix Pharmaceuticals Simon C Alison Tree 💙🇺🇦 Melvin LK CHUA
👏👏 impressive!! Congrats Telix Pharmaceuticals !! #TelixEMA Simon C Juan Antonio Vallejo #SinCienciaNoHayFuturo SEMNIM
Sumanta K. Pal, MD, FASCO for mentoring/powering me to #vailworkshop
Telix Pharmaceuticals @asxlongtail for tlx250 trial that got me into #vail2019
Great clinical and research mentors City of Hope including Dr. Caligiuri, Dr. Von Hoff, Dr Rosen, Dr Badie, Dr Bild, Dr Mortimer, Matt Loscalzo,
Yesterday at the ADM+S Centre + Sydney Law School Sydney Innovation Program, students got to hear from Rupal Ismin, Director of the Sydney Knowledge Hub, and Dr Kevin McCann AO, Chair of Telix Pharmaceuticals.
Brian Shuch, MD Telix Pharmaceuticals UCLA Urology @KidneyCancer UCLA Jonsson Comprehensive Cancer Center Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Toni Choueiri, MD Congratulations Brian Shuch, MD et al. Agree with Brian Rini, MD that this is very meaningful & novel and can open new directions & informative trial designs Sumanta K. Pal, MD, FASCO Toni Choueiri, MD Pavlos Msaouel Neeraj Agarwal, MD, FASCO Rana McKay Tian Zhang, MD, MHS Evan Hall Shailender Bhatia, MD Shilpa Gupta OncoAlert
Looking forward to celebrating SA’s #Health & #Medical Innovations sector at #APPLAUSE22 with our chair Sue MacLeman, our CEO Stuart Dignam, Chief Scientist for South Australia & Telix Pharmaceuticals's Dr David Cade!
Xenetic Biosciences is a biopharmaceutical company focused on advancing proprietary technology platforms across multiple high-value cancer indications. Learn more about us here: bit.ly/3xixJIx
$XBIO #Oncology #SolidTumors #PancreaticCancer #CARTcells
The 16th Annual Graduate Research Symposium is coming up on 19/11/2021!
Here are our first 3 amazing sponsors: Royal Australian Chemical Institute
Sapphire Bioscience & Telix Pharmaceuticals !
Remember to register via QR code to support your peers!
#ASCO21 Vision trial with 177Lu-PSMA-617 in mCRPC #prostatecancer 👉Main side effects here👇 @oncoalert PCF Science UroToday.com How easy it will be to obtain Gallium scan or PSMA Pet scan in the USA Telix Pharmaceuticals ?
Our CEO, John Climaco, speaks to the Company’s dedicated mission of not only providing hope for #Glioblastoma patients but also a safe and effective treatment option. #RareDiseaseDay #ShowYourStripes #CareAboutRare
Shankar Siva Melvin LK CHUA Piet Ost Jeremie Calais Michael Hofman ASCO Telix Pharmaceuticals Simon C Alison Tree 💙🇺🇦 This is very interesting data on PSMA-PET response. We are starting a trial with PSMA-PET at baseline for planning SBRT and one at 3 and another at 9-12m. Correlation with MRI and immunological biomarkers at similar times!
Hot of the press: Zircon phase III trial meets primary endpoint! Great news for our RCC patients - Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO Toni Choueiri, MD IKCC Kidney Cancer KCCure Telix Pharmaceuticals
telixpharma.com/news-views/zir…
Sumanta K. Pal, MD, FASCO UCLA Health Brian Shuch, MD ASCO Telix Pharmaceuticals Neeraj Agarwal, MD, FASCO Ulka Vaishampayan SWOG Cancer Research Network Petros Grivas Amar Kishan KidneyCAN @KidneyCancer Tian Zhang, MD, MHS Nazli Dizman Indeed! Congrats Brian Shuch, MD -you focused on this area for a long time, worked hard and this is the natural result!
Great panel on bridging the Gap between academic and commercial research VBIC Sally McArthur Kieran O'Brien Siemens Healthineers, Chris Behrenbruch Telix Pharmaceuticals,Tim O' Meara @GEHealthcare,Erol Harvey Australian National Imaging Facility. Neurosciences Victoria
